Concorde Asset Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
AIM
NAMA
KA
CS
Concorde Asset Management's TDOC Position: Q4 2021 in Review
Concorde Asset Management sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 4,826 shares — an estimated $612K sold.
Concorde Asset Management first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $2.43M in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.
- Concorde Asset Management reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
- Concorde Asset Management sold 4,826 Teladoc Health shares in Q4 2021, an estimated $612K.
- Concorde Asset Management first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
- Concorde Asset Management's Teladoc Health position peaked at $2.43M in Q4 2020.
- 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.
Based on Concorde Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.